← Evidence map

ArticleCancer2020

Life under the CABOSUN: Cabozantinib improves quality-adjusted survival in comparison with sunitinib.

Jeanny B Aragon-Ching et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2020
2021
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33022092